1-6 of 6
Mikel Lipschitz, M.S.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Title: Clinical and Biological Evaluation of the Novel CD30/CD16A Tetravalent Bispecific Antibody (AFM13) in Relapsed or Refractory CD30-Positive Lymphoma with Cutaneous Presentation: A Biomarker Phase Ib/IIa Study (NCT03192202)

Ahmed Sawas, MD, Pei-Hsuan Chen, Mikel Lipschitz, M.S., Scott Rodig, MD PhD, George Vlad
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-140096
Published: 2020
Journal Articles

PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation

Philippe Armand, MD PhD, Yi-Bin Chen, MD, Robert A. Redd, MS, Robin M. Joyce, MD, Jad Bsat, BA, Reid W Merryman, MD, Kimberly Coleman, RN, Parastoo B. Dahi, MD, Yago Nieto, MD PhD, Ann S. LaCasce, MD MSc, David C. Fisher, MD, Samuel Y. Ng, MDPhD, Oreofe O. Odejide, MD, Arnold S. Freedman, MD, Austin I Kim, MD, Jennifer L Crombie, MD, Caron A. Jacobson, MD, Eric D Jacobsen, MD, Jeffrey L Wong, MD PhD, Mikel Lipschitz, M.S., Sanjay S Patel, MD MSc, MPH, Jerome Ritz, MD PhD, Scott J Rodig, MDPhD, Margaret A. Shipp, MD, Alex F Herrera, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1650.
https://doi.org/10.1182/blood-2018-99-113685
Published: 2018
Journal Articles

Integrated Genetic and Topological Analysis Reveals a Hodgkin-like Mechanism of Immune Escape in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma

Gabriel K Griffin, MD, Margaretha G.M. Roemer, PhD, Mikel Lipschitz, M.S., Jason Weirather, PhD, Christine J. Pak, Allysa Kelly, Daniel Gusenleitner, PhD, Evisa Gjini, PhD, Bjoern Chapuy, MDPhD, Jie Xu, MD PhD, Benjamin Chen, MD PhD, Aliyah R. Sohani, MD, Scott B Lovitch, MD, PhD, Christopher Fletcher, MD, Gordon J Freeman, PhD, Stephen Hodi, Philippe Armand, MD PhD, Azra H. Ligon, PhD, Margaret A. Shipp, MD, Scott J Rodig, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1579.
https://doi.org/10.1182/blood-2018-99-118610
Published: 2018
Journal Articles

Axicabtagene Ciloleucel in the Real World: Outcomes and Predictors of Response, Resistance and Toxicity

Caron A. Jacobson, MD, Bradley Hunter, MD MPH, Philippe Armand, MD PhD, Yusuke Kamihara, MD PhD, Jerome Ritz, MD PhD, Scott J Rodig, MD, Kyle Wright, MD, PhD, Mikel Lipschitz, M.S., Robert A. Redd, MS, Marcela V. Maus, MD PhD, Yi-Bin Chen, MD, Jeremy S. Abramson, MD MMSc, Justin Kline, MD, Jonathon B. Cohen, MDMS, Joseph Maakaron, MD, Samantha Jaglowski, MDMPH, Stephen D. Smith, MD, David G. Maloney, MD PhD, Ajay K. Gopal, MD, Matthew J. Frigault, MD, Utkarsh H. Acharya, DO
Journal: Blood
Blood (2018) 132 (Supplement 1): 92.
https://doi.org/10.1182/blood-2018-99-117199
Published: 2018
Journal Articles

Analysis of CAR-T and Immune Cells within the Tumor Micro-Environment of Diffuse Large B-Cell Lymphoma Post CAR-T Treatment By Multiplex Immunofluorescence

Pei-Hsuan Chen, PhD, Mikel Lipschitz, M.S., Kyle Wright, MD, PhD, Philippe Armand, MD PhD, Caron A. Jacobson, MD MMSc, Zachary J. Roberts, MD, PhD, John M. Rossi, MS, Adrian Bot, MD PhD, William Y. Go, MD PhD, Scott J Rodig, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 678.
https://doi.org/10.1182/blood-2018-99-113644
Published: 2018
Journal Articles

Clinical and Biological Evaluation of the Novel CD30/CD16A Tetravalent Bispecific Antibody (AFM13) in Relapsed or Refractory CD30-Positive Lymphoma with Cutaneous Presentation: A Biomarker Phase Ib/IIa Study (NCT03192202)

Ahmed Sawas, MD, Hager Elgedawe, George Vlad, PhD, Mikel Lipschitz, M.S., Pei-Hsuan Chen, PhD, Scott J Rodig, MD, Jennifer Kimberly Lue, MD, Changchun Deng, MD PhD, Jennifer E Amengual, MD, Maher Abdul Hay, MD, Karen Khan, BSN, Laine E. Atkins, RN, Aishling M. Rada, RN, Larisa Geskin, MD, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2908.
https://doi.org/10.1182/blood-2018-99-115269
Published: 2018